Orbit MRI is one of the most technically demanding and clinically valuable examinations in diagnostic radiology. The orbit — the bony socket housing the eyeball, extraocular muscles, optic nerve, lacrimal gland, and surrounding fat — is a compact anatomical region where millimeter-level resolution can determine whether a patient loses vision or keeps it.
Orbit MRI is one of the most technically demanding and clinically valuable examinations in diagnostic radiology. The orbit — the bony socket housing the eyeball, extraocular muscles, optic nerve, lacrimal gland, and surrounding fat — is a compact anatomical region where millimeter-level resolution can determine whether a patient loses vision or keeps it.
Unlike CT, which excels at showing bony detail, orbit MRI provides unmatched soft-tissue contrast, making it the preferred modality for evaluating orbital masses, optic neuritis, retinoblastoma staging, and inflammatory pseudotumors. Understanding this scan is essential for both patients anticipating the procedure and MRI professionals preparing for registry examinations.
The technical setup for an orbit MRI differs meaningfully from a routine brain scan. Most protocols use a dedicated surface coil or a small field-of-view (FOV) head coil positioned directly over the orbits to maximize signal-to-noise ratio (SNR). Slice thickness typically drops to 2–3 mm, compared with the 5 mm slices common in brain imaging, and the matrix size increases to capture fine anatomical detail within structures as small as the ciliary body or the individual rectus muscle bellies.
The increased resolution comes at the cost of longer acquisition times, so patient cooperation and eye stillness are critical throughout the examination.
Radiologists and technologists must understand that the orbital fat creates an extremely bright signal on standard T1-weighted sequences, which can obscure adjacent pathology. Fat suppression techniques — including short tau inversion recovery (STIR), chemical-shift fat saturation, and Dixon methods — are therefore fundamental to virtually every orbit MRI protocol. The choice of fat suppression method depends on field strength, field homogeneity, and the specific clinical question. At 3T scanners, chemical-shift fat saturation is generally more effective than at 1.5T, but susceptibility artifacts near air-tissue interfaces in the sinuses can degrade fat suppression uniformly across the orbit.
Gadolinium-based contrast agents play a prominent role in orbit MRI when evaluating masses, vascular lesions, and inflammatory conditions. Post-contrast T1 fat-suppressed sequences highlight enhancing tumors, lymphomatous infiltration, and the optic nerve sheath in cases of meningioma or optic neuritis with blood-brain barrier breakdown. Some protocols also include dynamic contrast-enhanced (DCE) sequences to characterize the wash-in and wash-out kinetics of orbital lesions, using the same pharmacokinetic principles applied in breast and prostate MRI. The decision to use contrast should always weigh the diagnostic benefit against gadolinium deposition concerns, particularly in pediatric patients.
For MRI registry candidates, orbit imaging questions frequently appear in the anatomy and pathology domain. The examiner may ask about the normal signal intensity of orbital fat on T1 versus T2 sequences, the MRI appearance of a cavernous hemangioma versus a capillary hemangioma, or the classic dural tail sign associated with optic nerve sheath meningioma. You can sharpen these skills by working through an orbit mri knowledge base alongside dedicated practice tests that mirror real registry question formats.
The clinical indications for orbit MRI span a wide spectrum of pathology, from benign dermoid cysts and thyroid-associated orbitopathy to aggressive primary tumors and metastatic deposits. Emergency indications include suspected orbital apex syndrome, cavernous sinus thrombosis with orbital extension, and traumatic optic neuropathy in patients who cannot tolerate CT contrast.
In these acute scenarios, the MRI technologist must execute the protocol efficiently while ensuring absolute safety — metallic intraocular foreign bodies (IOFBs) represent a contraindication that must be screened for before every single orbital scan, since even a tiny metal fragment can rotate catastrophically within the magnetic field and cause permanent blindness.
This comprehensive guide walks through orbital anatomy visible on MRI, standard imaging protocols, key pathological findings, patient preparation, and the safety considerations every technologist must master. Whether you are a patient trying to understand what the radiologist will see, a student preparing for board examinations, or an experienced technologist refining your orbital protocols, the sections below provide the depth and clinical context you need to approach orbit MRI with confidence.
The optic nerve runs from the posterior globe through the optic canal to the chiasm. On T2 fat-suppressed images, the nerve appears as a dark cord surrounded by bright cerebrospinal fluid within the dural sheath — a finding critical for diagnosing optic neuritis and meningioma.
Six muscles control eye movement and are individually identifiable on coronal MRI slices. Enlargement of specific muscles points to different diagnoses: thyroid orbitopathy typically spares the tendons, while orbital myositis involves the entire muscle including the tendinous insertion.
Intraconal fat lies inside the muscle cone and appears very bright on T1 sequences. Extraconal fat occupies the peripheral orbit. Replacement or displacement of orbital fat by a mass helps determine whether a lesion is intra- or extraconal, which directly guides the differential diagnosis.
Located in the superolateral orbit, the lacrimal gland measures approximately 20 mm and shows intermediate T1 signal. Enlargement raises concern for sarcoidosis, lymphoma, or dacryoadenitis. Bilateral symmetric enlargement with parotid involvement strongly suggests sarcoid or IgG4-related disease.
The vitreous humor appears very bright on T2 and dark on T1. The retina, choroid, and sclera form the posterior globe wall. Retinal detachment creates a V-shaped T2 hyperintense collection, while uveal melanoma shows characteristic T1 hyperintensity due to melanin paramagnetic effects.
A well-designed orbit MRI protocol balances spatial resolution, tissue contrast, and acquisition time while remaining adaptable to the clinical question. Most institutions anchor their orbital protocol on three core sequences: T1 without fat suppression, T2 with fat suppression (or STIR), and T1 fat-suppressed post-contrast. From this base, additional sequences are added depending on the suspected diagnosis.
Diffusion-weighted imaging (DWI) is increasingly incorporated, particularly when orbital abscess, epidermoid cyst, or lymphoma is suspected, because these entities show restricted diffusion that distinguishes them from mimics. Understanding DWI principles is explored in depth on our orbit MRI resource pages, where sequence physics are explained alongside clinical examples.
The T1 non-fat-suppressed sequence is typically performed in axial and coronal planes at 3 mm slice thickness. This sequence beautifully depicts orbital fat, the vitreous, the optic nerve sheath complex, and any T1-hyperintense lesion such as subacute hemorrhage, melanin-containing tumors, or proteinaceous fluid. The absence of fat suppression means the bright orbital fat provides a natural background against which darker lesions are easily identified. Vascular flow voids can also be appreciated, which is useful when arteriovenous malformations or cavernous sinus pathology is part of the differential diagnosis during the pre-contrast review.
T2 fat-suppressed imaging, often acquired with STIR at 1.5T or with spectral presaturation with inversion recovery (SPIR) at 3T, is arguably the single most important sequence for orbital pathology. STIR suppresses fat signal based on its short T1 relaxation time and is relatively insensitive to field inhomogeneity — a major advantage near the sinus air-tissue interfaces that cause B0 variations throughout the orbit.
The sequence reveals edematous optic nerve, inflamed extraocular muscles, orbital cellulitis, and the nerve sheath fluid in optic nerve sheath meningioma with striking clarity. Slice thickness of 2–3 mm in both axial and coronal planes is standard practice at most academic centers.
Post-contrast T1 fat-suppressed sequences should be acquired in at least two planes, with many protocols adding a third (sagittal oblique) plane aligned with the optic nerve long axis to evaluate the entire nerve from globe to chiasm. This oblique plane is particularly valuable when optic neuritis or glioma is suspected and the radiologist needs to map disease extent for treatment planning.
The timing of post-contrast imaging matters: most orbital masses show persistent enhancement, so immediate post-injection imaging is acceptable, but some vascular lesions — particularly low-flow venous malformations — may demonstrate progressive fill-in on delayed sequences obtained 5–10 minutes after injection.
At higher field strengths, 3D volumetric sequences with isotropic voxels (typically 0.6–1.0 mm³) are becoming standard for pre-surgical orbital planning and for evaluating the cavernous sinus region when orbital apex pathology is suspected. Volumetric T1 MPRAGE (Magnetization Prepared Rapid Gradient Echo) and 3D SPACE (Sampling Perfection with Application-optimized Contrasts using different flip-angle Evolution) T2 sequences provide multiplanar reformats without penalty to resolution. The trade-off is longer acquisition time and greater susceptibility to motion artifacts, which requires robust patient preparation and, in some pediatric cases, conscious sedation or general anesthesia to maintain necessary stillness throughout the protocol.
Magnetic resonance angiography (MRA) of the orbital vasculature may be appended to the orbital protocol when a vascular lesion — such as a dural cavernous sinus fistula, orbital varix, or arteriovenous malformation — is included in the differential diagnosis. Time-of-flight (TOF) MRA without contrast can demonstrate the ophthalmic artery and its branches, while gadolinium-enhanced MRA provides superior delineation of venous structures and the superior ophthalmic vein, which drains arteriovenous fistulas. Vascular MRA sequences add approximately 5–8 minutes to total scan time and require no additional contrast injection when performed immediately after the standard post-contrast orbital series.
Functional and advanced sequences are pushing the frontier of orbit MRI beyond morphological imaging. Diffusion tensor imaging (DTI) can now track optic nerve fiber integrity and detect subtle axonal damage in optic neuritis or compressive optic neuropathy before visible structural changes occur on conventional sequences.
Arterial spin labeling (ASL) perfusion and magnetic resonance spectroscopy (MRS) remain largely investigational for orbital applications but are being studied in the context of orbital tumor characterization. For the practicing technologist and registry candidate alike, a firm grasp of the foundational sequences — T1, T2-STIR, and post-contrast T1 fat-suppressed — remains the essential starting point for understanding all orbital MRI examinations.
Cavernous hemangioma is the most common benign orbital mass in adults, typically appearing as a well-defined intraconal lesion with homogeneous low T1 and very high T2 signal. On post-contrast imaging, it shows a characteristic progressive enhancement pattern — the lesion fills in from periphery to center on delayed images. This progressive fill-in distinguishes cavernous hemangioma from lymphangioma, which shows heterogeneous T2 signal due to fluid-fluid levels from repeated internal hemorrhages. Dermoid cysts, another common benign mass, are almost always located at the frontozygomatic suture and contain fat-bright signal on T1 that suppresses on fat-sat sequences.
Malignant orbital masses include rhabdomyosarcoma (the most common primary orbital malignancy in children), lymphoma in adults, and metastatic deposits from breast, lung, or prostate carcinoma. Rhabdomyosarcoma presents as an aggressive, poorly marginated mass with intermediate T1 and heterogeneous T2 signal, often showing restricted diffusion on DWI with ADC values below 1.0 × 10⁻³ mm²/s. Lymphoma classically molds to orbital structures without displacement — the so-called salmon-patch lesion seen subconjunctivally — and shows markedly restricted diffusion due to its dense cellularity, an important discriminator from the lower cellularity of benign orbital pseudotumor.
Thyroid-associated orbitopathy (TAO), also called Graves' orbitopathy, is the most common cause of orbital and periorbital swelling in adults and represents a frequent indication for orbit MRI. The hallmark finding is enlargement of extraocular muscle bellies with relative tendon sparing — the inferior and medial rectus muscles are most commonly affected, followed by superior and lateral rectus. On T2-STIR sequences, actively inflamed muscles show high signal due to edema, which is a useful indicator of disease activity and helps guide decisions about steroid therapy versus surgical orbital decompression. The optic nerve should always be evaluated for compression at the orbital apex when muscle enlargement is pronounced.
Orbital pseudotumor (idiopathic orbital inflammatory syndrome) is a diagnosis of exclusion that can mimic virtually every other orbital condition. It typically presents acutely with pain, proptosis, and restricted eye movement. MRI shows diffuse infiltration of orbital fat with poorly defined margins, muscle enlargement including tendon involvement, and sometimes scleral or uveal thickening. The dramatic and rapid response to corticosteroids — often within 24–48 hours — is both diagnostic and therapeutic. When the clinical response is incomplete or atypical, biopsy is required to exclude lymphoma, IgG4-related disease, or granulomatous conditions such as sarcoidosis or Wegener granulomatosis.
Optic neuritis is one of the most clinically important diagnoses made on orbit MRI and is strongly associated with multiple sclerosis (MS). The classic MRI finding is T2/STIR hyperintensity and enhancement of the optic nerve, which may be segmental or involving the full length of the nerve. The Optic Neuritis Treatment Trial established that gadolinium-enhancing optic neuritis carries a significantly higher risk of conversion to MS within 15 years, making the post-contrast fat-suppressed T1 sequence critical for prognostic information. A normal baseline brain MRI at the time of first optic neuritis episode carries a much lower MS conversion risk than one with white matter lesions.
Optic nerve sheath meningioma arises from arachnoid cap cells along the optic nerve sheath and produces a distinctive tram-track sign on axial post-contrast images — enhancing tumor surrounds the non-enhancing optic nerve, creating two parallel enhancement lines. This appearance is essentially pathognomonic and usually obviates biopsy. Optic nerve gliomas, by contrast, expand the nerve itself and are frequently associated with neurofibromatosis type 1 (NF1) in children. Cavernous sinus thrombosis with orbital extension presents with proptosis, chemosis, and CN III–VI deficits; MRI shows loss of the normal venous flow void in the cavernous sinus with surrounding dural enhancement and orbital congestion.
Metallic intraocular foreign bodies are an absolute contraindication to MRI. Even a tiny ferromagnetic metal fragment — too small to be felt or seen — can torque within the magnetic field and lacerate the retina or optic nerve, causing permanent blindness. Any patient with a history of metalworking, grinding, or eye trauma must have plain orbital X-rays or a CT scan completed before entering the MRI room, regardless of symptom onset or urgency. This rule is non-negotiable and must be verified by the technologist at every orbit MRI examination.
Safety considerations for orbit MRI extend well beyond the metallic intraocular foreign body screening that receives the most attention. Ocular implants represent a heterogeneous category of devices, and the MRI compatibility of each must be verified against the implant manufacturer's documentation and the current MRI safety labeling.
Retinal tacks used to repair detachments, scleral buckles, and certain glaucoma drainage implants have historically contained ferromagnetic materials, though most modern devices are MRI conditional at specified field strengths and specific absorption rates (SAR). The technologist must obtain the exact device name, model number, and manufacturer before scanning any patient with prior ocular surgery.
Cochlear implants — while not orbital devices — frequently appear in the clinical history of patients referred for orbit MRI because both the ear canal and the orbits are scanned in neuro-otology protocols. Standard cochlear implants are generally contraindicated in MRI unless they have a magnet-removable design or have received specific MRI conditional labeling.
The magnetic component of a cochlear implant can demagnetize within the MRI bore, causing device malfunction and significant patient discomfort from torque forces. When orbit MRI is essential and a cochlear implant cannot be removed, consultation with the implant manufacturer and the patient's otolaryngologist is required before proceeding.
Acoustic noise in modern high-field MRI systems reaches levels of 110–120 dB(A) during fast gradient sequences. While this is well below the threshold for acute auditory damage during a single examination, hearing protection is mandatory as a standard precaution. More practically, the startling nature of gradient noise can cause involuntary eye movement that degrades orbital image quality. Taking two minutes to explain the noise pattern and offer earplugs dramatically reduces motion artifacts and improves overall scan quality — a simple intervention with measurable diagnostic impact that every orbital MRI technologist should perform as routine practice.
Pediatric patients undergoing orbit MRI for retinoblastoma staging or other childhood orbital tumors present unique safety and practical challenges. Children under approximately 7–8 years of age typically require conscious sedation or general anesthesia to achieve the immobility needed for high-resolution orbital images. The MRI team must coordinate with anesthesiology to ensure that all anesthesia equipment entering the MRI room is MRI-compatible — ferromagnetic anesthesia machines, gas cylinders, and infusion pumps have caused serious accidents in MRI facilities. Additionally, pediatric orbital protocols should minimize gadolinium doses and use weight-based dosing (0.1 mmol/kg) to limit cumulative gadolinium deposition across multiple staging examinations.
Pregnancy presents a nuanced safety scenario for orbit MRI. The American College of Radiology (ACR) guidance states that MRI can be performed at any gestational age when the benefit to the mother outweighs theoretical risks to the fetus, and no acoustic or thermal harm to the fetus has been demonstrated in peer-reviewed literature. Gadolinium contrast, however, crosses the placenta and accumulates in amniotic fluid, where it can remain for extended periods with unknown biological consequences.
The ACR therefore recommends using gadolinium in pregnant patients only when it is absolutely necessary for diagnosis and the information cannot be obtained by non-contrast MRI. For orbital pathology, non-contrast fat-suppressed sequences often provide sufficient diagnostic information to defer contrast administration until after delivery.
Claustrophobia affects approximately 1–2% of patients undergoing MRI and can be particularly challenging during orbital imaging because the patient's face is positioned close to the bore ceiling with a surface coil directly over the eyes. Short-bore wide-bore magnets (≥70 cm bore diameter) significantly reduce claustrophobic reactions compared with traditional 60 cm bore systems.
For patients with known claustrophobia, oral anxiolytic premedication, verbal reassurance throughout the scan, and the option to use a mirror attachment to see outside the bore are effective mitigation strategies. Open-configuration MRI systems operating at 0.3–0.7T can accommodate the most severely claustrophobic patients but sacrifice the resolution needed for diagnostic orbital imaging in most clinical scenarios.
Radiofrequency (RF) energy deposition during MRI is quantified by specific absorption rate (SAR), measured in watts per kilogram. High-SAR sequences — particularly fast spin echo T2 sequences with short echo spacing and numerous refocusing pulses — can cause localized heating, which is a theoretical concern near any implanted metallic device and in patients with conditions that impair thermoregulation.
For orbital imaging, the proximity of the surface coil to superficial structures means that local SAR near the eye can be higher than the whole-body SAR displayed on the console, a nuance that experienced MRI physicists and technologists factor into their protocol design. Most modern scanners automatically modulate flip angles and repetition times to maintain SAR within FDA-mandated limits during orbital acquisitions.
Preparing for the MRI registry examination requires more than memorizing normal anatomy — it demands a working clinical understanding of how pathological processes alter signal characteristics on each sequence and why specific protocols are designed the way they are. Orbit MRI questions on the ARRT advanced MRI examination appear primarily within the Anatomy and Pathology content domain, which accounts for a substantial percentage of total exam content.
Candidates who score highest in this domain consistently demonstrate the ability to reason through a clinical scenario — given a patient presentation, identifying which sequences best demonstrate the pathology and which imaging findings confirm the diagnosis.
One of the most high-yield orbital topics for registry preparation is the differentiation of intraconal versus extraconal lesions. Intraconal lesions arise within the muscle cone and include cavernous hemangioma, optic nerve glioma, optic nerve sheath meningioma, and metastases. Extraconal lesions arise outside the muscle cone and include dermoid cysts, lacrimal gland tumors, and subperiosteal abscesses from adjacent sinusitis.
This anatomical distinction drives the differential diagnosis because the vascular supply, surgical approach, and prognosis differ fundamentally between the two spaces. On registry examinations, a coronal MRI image showing a well-defined T2-bright mass centered within the muscle cone should immediately trigger consideration of cavernous hemangioma as the most likely diagnosis in an adult patient.
Understanding signal intensity relationships is fundamental to answering orbital MRI questions correctly. The standard signal intensity hierarchy for orbital fat on T1 is: orbital fat (very bright) > subacute blood (bright) > normal brain white matter (intermediate-bright) > gray matter (intermediate) > muscle (intermediate-dark) > cortical bone and air (dark). On T2 STIR with fat suppression, this hierarchy inverts for fat — which becomes dark — while free water structures like vitreous humor and CSF within the optic nerve sheath become very bright.
Melanin in uveal melanoma is paramagnetic and causes T1 shortening, creating a characteristic high T1 signal that is unique among orbital masses and represents a registry-worthy distinguishing feature.
Artifact recognition is another domain where orbital MRI questions frequently appear. Susceptibility artifacts from dental amalgam, eyelid piercings, or residual metallic orbital implants cause signal voids and geometric distortion that are most pronounced on gradient echo sequences and EPI-based DWI.
Chemical shift artifact appears at fat-water interfaces such as the orbital fat-muscle border on non-fat-suppressed T1 sequences, creating a bright band on one side and a dark band on the other depending on frequency encoding direction. Motion artifact from involuntary eye movement creates ghosting in the phase-encoding direction — understanding why the ghosting appears in a specific direction based on the sequence orientation is a concept directly tested on registry examinations.
Time management strategy matters enormously during the registry examination, and orbital anatomy questions tend to require more cognitive time than calculation-based physics questions. Experienced candidates recommend working through the anatomy and pathology domain in a deliberate pass, flagging any question where you are less than 80% confident, completing the remaining domains, and returning to flagged questions with fresh eyes.
Because orbital MRI questions often include high-resolution image vignettes, having a systematic approach — identify the plane, identify fat suppression status, identify the lesion's location relative to the muscle cone, characterize T1 and T2 signal, note enhancement pattern — prevents cognitive overload and ensures consistent answer quality across the most challenging image-based questions.
Practice tests remain the most evidence-supported preparation strategy for registry examinations. Repeated exposure to question formats that mirror the actual examination trains your retrieval efficiency and identifies knowledge gaps that targeted review can then address. The ARRT examination uses both standalone multiple-choice questions and image-based questions, and the latter require the ability to recognize pathology on actual MRI images rather than text descriptions alone.
Supplementing written study guides with image review sessions using a radiology atlas or online case libraries builds the pattern recognition that distinguishes candidates who pass comfortably from those who pass by narrow margins — or do not pass on their first attempt.
The clinical relevance of orbit MRI knowledge extends far beyond examination success. As MRI technology continues to advance — with ultra-high-field 7T systems entering clinical use, AI-assisted protocol optimization becoming mainstream, and hybrid PET-MRI units enabling simultaneous metabolic and morphological orbital tumor characterization — the foundational understanding of orbital anatomy, signal behavior, and protocol design principles will remain the essential scaffolding on which all future technical innovation builds.
Technologists and radiologists who invest deeply in this foundational knowledge will be equipped not only to pass today's registry examination but to adapt intelligently to the orbital imaging innovations of the next decade.
Practical excellence in orbit MRI begins before the patient enters the MRI room. A thorough pre-scan review of the clinical history, the referring physician's question, and any prior imaging is not a bureaucratic formality — it is the single intervention most likely to improve scan quality and diagnostic yield.
A technologist who knows that the clinical question is optic neuritis will prioritize high-quality T2-STIR and post-contrast fat-suppressed T1 sequences and will coach the patient specifically about gaze fixation. One who scans without reviewing the request may acquire a technically adequate but diagnostically insufficient protocol that requires a repeat examination, doubling patient exposure and scanner utilization.
Coil selection and positioning are the next critical determinants of orbital MRI quality. A dedicated small orbital surface coil provides dramatically higher SNR than a standard head coil for superficial orbital structures, particularly the anterior globe, eyelid margin, and lacrimal gland.
When a surface coil is unavailable, the most anterior elements of a 20-channel or 32-channel head coil array should be selected and the patient positioned as anteriorly within the bore as anatomically possible to maximize coil-element proximity to the orbit. Some institutions use flexible wrap-around coils that conform to the orbital contours, providing a practical compromise between dedicated surface coil performance and head coil coverage.
Sequence prescription requires careful alignment of imaging planes to orbital anatomy rather than to standard head orientations. The axial plane for orbital imaging is typically prescribed parallel to the optic nerve axis — a line from the posterior globe to the optic chiasm — rather than parallel to the anterior commissure-posterior commissure (AC-PC) line used for brain MRI.
This subtle reorientation ensures that the optic nerve is imaged in true cross-section on coronal views and in true long-axis on axial views, which is critical for accurately characterizing optic nerve lesion extent and for detecting the subtle perilesional enhancement seen in early optic neuritis.
Eye motion remains the dominant source of image degradation in orbit MRI, and managing it requires both technical and interpersonal strategies. Technically, acquiring the most motion-sensitive sequences (DWI, post-contrast 3D) during the second half of the examination gives the patient time to acclimate and settle into the scanner environment.
Interpersonally, clear scripted instructions delivered in plain language — tell the patient to look at the inside top of the scanner tunnel, pick a spot, and try to hold that gaze without moving — consistently outperform vague requests to stay still. Some protocols briefly tape the eyelids gently closed for specific sequences; when this is done, explaining the purpose beforehand prevents the patient from reflexively opening their eyes at the moment the tape is applied.
Fat suppression quality should be evaluated on the first scout image before proceeding with the full protocol. Uneven fat suppression — appearing as regional bands of bright fat signal amidst otherwise suppressed tissue — indicates B0 field inhomogeneity that should be corrected by rerunning the automated shimming routine or manually adjusting shim parameters over a region of interest centered on the orbits.
At 3T, the smaller bandwidth of water and fat spectral peaks relative to frequency separation makes chemical-shift fat suppression more reliable than at 1.5T in most patients, but near the ethmoid and maxillary sinuses, residual fat signal from incomplete suppression can be misinterpreted as enhancing pathology if not recognized on pre-contrast comparison images.
Documentation and communication complete the orbit MRI workflow. The technologist should note any deviation from the standard protocol — a sequence repeated due to motion, a plane added at the radiologist's request, gadolinium dose modification for renal impairment — directly in the examination record.
If the technologist identifies an incidental finding during the scan (for example, a globe that appears markedly enlarged suggesting buphthalmos, or obvious proptosis on the scout localizer that was not mentioned in the clinical history), flagging this to the reading radiologist before the patient leaves the department allows for protocol expansion or clinical triage without scheduling a second visit. This proactive communication is one of the hallmarks of an experienced MRI technologist and directly improves patient care outcomes.
Continuous professional development in orbit MRI requires deliberate engagement with current literature and case conferences. The American Journal of Neuroradiology (AJNR) and Radiology regularly publish orbital MRI case series and technical innovations. ARRS and RSNA annual meetings feature orbital imaging sessions where new protocol strategies and rare pathologies are presented with high-quality image examples. Building a personal reference library of characteristic orbital MRI findings — curating one representative case for each major diagnosis covered in this guide — creates a mental image bank that improves both registry examination performance and real-world clinical scanning competence over the course of a career.